Autolus Therapeutics plc

AUTL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001730463

SEC filings (opens in a new tab)

In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Autolus Therapeutics plc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of AUTL: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	99	120	+21
Shares	115.9M	175.7M	+59.7M (+51.5%)
Value	$746.6M	$1.12B	+$374.0M (+50.1%)

New holders (27)

Institutions that held Autolus Therapeutics plc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to AUTL in Q1 2024
Institution	Shares	Value	% of portfolio
Avoro Capital Advisors LLC	12,345,678	$78.8M	0.92%
Wellington Management Group LLP	10,763,001	$68.7M	0.01%
Deerfield Management Company, L.P. (Series C)	3,639,000	$23.2M	0.40%
Commodore Capital LP	2,300,000	$14.7M	0.98%
Bank of New York Mellon Corp	1,450,791	$9.26M	0.00%
Great Point Partners LLC	1,166,667	$7.44M	1.16%
Rock Springs Capital Management LP	1,032,988	$6.59M	0.17%
Driehaus Capital Management LLC	676,025	$4.31M	0.04%
Voloridge Investment Management, LLC	512,847	$3.27M	0.01%
Integral Health Asset Management, LLC	500,000	$3.19M	0.31%
Monashee Investment Management LLC	492,000	$3.14M	0.37%
Nomura Asset Management Co Ltd	384,796	$2.45M	0.01%
HighVista Strategies LLC	261,324	$1.67M	0.59%
Voya Investment Management LLC	205,225	$1.31M	0.00%
Octagon Capital Advisors LP	176,000	$1.12M	0.14%
Balyasny Asset Management LLC	60,928	$388.7K	0.00%
Allianz Asset Management GmbH	38,700	$246.9K	0.00%
Point72 Asset Management, L.P.	37,300	$238.0K	0.00%
SG Americas Securities, LLC	19,853	$127.0K	0.00%
Ameriprise Financial Inc	16,692	$106.5K	0.00%
Bayesian Capital Management, LP	15,600	$99.5K	0.01%
Marex Group plc	12,500	$79.8K	0.00%
Franklin Resources Inc	10,000	$63.8K	0.00%
New York State Common Retirement Fund	7,370	$47.0K	0.00%
National Asset Management, Inc.	17,000	$39.6K	0.00%
Aquatic Capital Management LLC	3,100	$19.8K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	2,633	$16.8K	0.00%

Sold out (6)

Institutions that held Autolus Therapeutics plc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of AUTL in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Ikarian Capital, LLC	262,694	$1.69M
ExodusPoint Capital Management, LP	251,361	$1.62M
Walleye Trading LLC	44,633	$287.4K
Sierra Summit Advisors LLC	42,744	$275.3K
Boothbay Fund Management, LLC	29,822	$192.1K
Parkside Financial Bank & Trust	200	$1.29K